DiaSorin set to launch LIAISON SARS-CoV-2 IgG kit for testing COVID-19

pharmanewsdaily- April 13, 2020

LIAISON SARS-CoV-2 IgG kit : DiaSorin said that it has completed studies at the Policlinico San Matteo in Pavia, Italy to support the roll out ... Read More

Gilead Sciences wraps up $4.9bn acquisition of Forty Seven

pharmanewsdaily- April 13, 2020

Gilead Sciences has completed its previously announced $4.9 billion acquisition of Forty Seven, a clinical-stage immuno-oncology company based in California. The immuno-oncology company has been ... Read More

Vortran, Xerox to bulk produce GO2Vent ventilators for coronavirus patients

pharmanewsdaily- April 10, 2020

Vortran Medical Technology, a US medical device manufacturer, has partnered with Xerox to accelerate and scale production of the former’s GO2Vent disposable ventilators to aid ... Read More

Bio-Rad Laboratories launches serology assay to detect COVID-19 antibodies

pharmanewsdaily- April 9, 2020

Bio-Rad Laboratories, a medical laboratory chain, has launched a blood-based immune assay kit for the detection of COVID-19 antibodies. The serology kit has been developed ... Read More

Gilead Sciences, Second Genome form IBD drug discovery alliance

pharmanewsdaily- April 9, 2020

Gilead Sciences has entered into a four-year deal worth up to $338 million with California-based clinical-stage company Second Genome to discover targets and drug candidates ... Read More

Alnylam, Dicerna form RNAi collaboration for alpha-1 liver disease

pharmanewsdaily- April 8, 2020

Alnylam Pharmaceuticals and Dicerna Pharmaceuticals are joining forces to develop and commercialize ribonucleicacid interference therapies (RNAi therapeutics) for the treatment of alpha-1 antitrypsin deficiency-associated liver ... Read More

Servier to acquire Danish antibody discovery company Symphogen

pharmanewsdaily- April 8, 2020

Servier acquisition of Symphogen : French pharma company Servier has agreed to acquire Danish antibody discovery company Symphogen, for an undisclosed price to boost its ... Read More

XBiotech partners with BioBridge to develop plasma-based Covid-19 therapy

pharmanewsdaily- April 7, 2020

US biopharmaceutical company XBiotech has partnered with BioBridge Global to develop potential plasma-based Covid-19 therapy using natural antibodies from the convalescent plasma of recovered patients. ... Read More

Haemonetics acquires German medical technology manufacturer enicor

pharmanewsdaily- April 7, 2020

Haemonetics acquisition of enicor : US blood management company Haemonetics has acquired Germany-based medical technology manufacturer enicor, which manufactures the ClotPro whole blood coagulation testing ... Read More

LifeSignals to launch biosensor patch 1AX to monitor COVID-19 symptoms

pharmanewsdaily- April 6, 2020

LifeSignals is set to launch its single use, wireless medical biosensor patch 1AX for the early detection and to monitor COVID-19 symptoms in infected patients. ... Read More